Researchers investigated the potential association between psoriasis and clinical markers of cognitive decline using data from the Rotterdam Study.
FDA Alerts
FDA Alerts
Wednesday, June 20, 2018
The FDA has approved the inclusion of new evidence to the prescribing label for secukinumab for the treatment of psoriatic arthritis.
FDA Alerts
Tuesday, May 29, 2018
The FDA has approved expanding the indication for certolizumab pegol (Cimzia) to include adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
FDA Alerts
Wednesday, March 21, 2018
The FDA approved a new therapy for the treatment plaque psoriasis among adult patients. For administration and adverse effects, read more.
FDA Alerts
Tuesday, January 2, 2018
The FDA has approved a generic topical solution for the treatment of chronic, moderately severe psoriasis of the scalp.
News
News
Monday, August 20, 2018
Researchers investigated the potential association between psoriasis and clinical markers of cognitive decline using data from the Rotterdam Study.
News
Tuesday, August 14, 2018
Researchers investigated whether a biologic increased the risk for serious infections among patients with psoriasis.
News
Thursday, July 26, 2018
Results from a recent study show a potential association between adherence to a non-inflammatory diet and disease severity among patients with psoriasis.
News
Friday, July 20, 2018
Researchers investigated the efficacy of a topical combination treatment at reducing the signs and symptoms of psoriasis. For a breakdown of how the combination lotion compared to each individual therapy, read more.
NPF Endorsed Articles
NPF Endorsed Articles
Monday, August 6, 2018
Amar Majjhoo, MD, discusses what the Psoriatic Arthritis (PsA) Narrative Survey findings mean for clinicians and how they can be used to improve interactions with patients.
NPF Endorsed Articles
Friday, June 22, 2018
A review of recent news, research, and treatment related to psoriasis.
NPF Endorsed Articles
Wednesday, May 16, 2018
Psoriasis is associated with comorbid disease conditions that can significantly impact the quality of life for these patients.
NPF Endorsed Articles
Monday, March 26, 2018
The studies presented at 2018 American Academy of Dermatology Annual Meeting offered dermatologists the latest research and management approaches for psoriasis.
Quizzes
Quizzes
Tuesday, July 31, 2018
Which of the following is not a differential diagnosis of cutaneous T-cell lymphoma?
Research in Review
Research in Review
Tuesday, July 31, 2018
Recently approved therapies, drugs in development, and expanded labels for existing psoriasis drugs continue to offer clinicians and patients an expanding range of options for treatments.
Research in Review
Friday, July 27, 2018
The various presentations of psoriasis can make choosing from among the numerous treatment options overwhelming for patients and physicians. Treatment algorithms can help guide the decision.
Research in Review
Thursday, May 17, 2018
A review of recent news, research, and treatment related to psoriasis.
Research in Review
Tuesday, February 20, 2018
A review of recent news, research, and treatment related to psoriasis